Comprehensive Phosphodiesterase Screening Services for Drug Discovery
Phosphodiesterases (PDEs) represent a diverse family of enzymes renowned for their role in cellular signaling. By hydrolyzing cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), PDEs regulate essential physiological processes such as inflammation, neuronal plasticity, and metabolism. Given their extensive influence on cellular functions, targeting specific isoforms of these enzymes holds significant therapeutic potential.
Understanding PDEs
The PDE family consists of various isoforms, distinguished by their unique tissue distributions and substrate preferences. This heterogeneity offers exciting opportunities for drug development. Precise inhibition or activation of individual isoforms can elicit beneficial therapeutic effects while minimizing potential side effects associated with non-selective interactions. The clinical implications of such targeted approaches have led to increased interest in the inhibition of PDEs in treating various diseases, including cardiovascular conditions, respiratory issues, and neurological disorders.
Advanced Screening Techniques
At Creative Bioarray, our state-of-the-art PDE screening services utilize high-throughput Fluorescence Polarization (FP) technology. This method enables rapid assessment of the inhibitory effects of compounds on specific PDE subtypes, streamlining the drug discovery process. The underlying mechanism of this assay leverages the hydrolysis of fluorescently labeled substrates by PDEs. When compounds inhibit PDE activity, the fluorescent signal indicates their potential effectiveness, allowing for efficient screening of numerous candidates.
Detection Targets
Our PDE screening services cover a wide array of targets relevant to drug development. The following list showcases notable PDE subtypes available for screening:
PDE1A
PDE1B
PDE1C
PDE2A1
PDE3A
PDE3B
PDE4A1A
PDE4A10
PDE4B1
PDE4B2
PDE4C1
PDE4D2
PDE4D3
PDE4D7
PDE5A1
PDE6C
PDE7A
PDE7B
PDE8A
PDE9A2
PDE10A1
PDE10A2
PDE11A
Service Features
Our PDE screening services offer several advantages:
- High-Throughput and Efficiency: Advanced FP platforms facilitate quick screening of vast compound libraries, significantly reducing the time required for discovery.
- Precision and Reliability: Rigorous internal validation ensures accurate and reproducible data results.
- Expert Team: Our skilled pharmacology and enzymology professionals provide comprehensive experimental design and data analysis support.
- Customizable Solutions: Tailored services accommodate client-specific needs, enhancing the relevance and applicability of our offerings.
Conclusion
With a profound understanding of PDEs and their implications in drug development, Creative Bioarray stands at the forefront of innovative screening solutions. By harnessing advanced technology and expertise, we facilitate the identification of promising compounds, paving the way for future therapeutic discoveries. For inquiries and additional information about our phosphodiesterase screening services, please reach out to our customer service representatives, available around the clock.
- Like
- Reply
-
Share
Reply
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2026 MolecularCloud